Bluejay Diagnostics Files 8-K: Officer & Director Changes
Ticker: BJDX · Form: 8-K · Filed: May 28, 2025 · CIK: 1704287
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
Related Tickers: BJDX
TL;DR
Bluejay Diagnostics (BJDX) filed an 8-K for director/officer changes and comp arrangements. Details TBD.
AI Summary
Bluejay Diagnostics, Inc. filed an 8-K on May 28, 2025, reporting changes in its board of directors and certain officers, along with updates on compensatory arrangements. The filing also includes financial statements and exhibits, though specific details on dollar amounts or new appointments were not immediately available in the provided text.
Why It Matters
Changes in a company's leadership and compensation structures can signal shifts in strategy or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Filings related to executive and board changes can indicate internal shifts that may affect company direction and stability.
Key Players & Entities
- Bluejay Diagnostics, Inc. (company) — Registrant
- May 28, 2025 (date) — Date of earliest event reported
FAQ
What specific changes were made regarding directors or officers?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers', but the specific names and roles are not detailed in the provided text.
Are there any new compensatory arrangements disclosed?
The filing mentions 'Compensatory Arrangements of Certain Officers', but the specifics of these arrangements are not provided in the excerpt.
What is the exact date of the earliest event reported in this 8-K?
The date of the earliest event reported is May 28, 2025.
What is Bluejay Diagnostics' principal executive office address?
The principal executive offices are located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.
What is the SIC code for Bluejay Diagnostics, Inc.?
The Standard Industrial Classification (SIC) code for Bluejay Diagnostics, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding Bluejay Diagnostics, Inc. (BJDX).